Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current EPS (TTM) is 4,62 €. In 2022 the company made an earnings per share (EPS) of -4,36 € a decrease over its 2021 EPS that were of 2,31 €.